by John Warren | Oct 15, 2024
As Medicare Advantage (MA) continues its impressive growth trajectory, with over 34 million enrollees, the recent announcement of significant plan reductions may seem surprising. Yet, the withdrawal of major insurers from certain markets is not necessarily a...
by John Warren | Oct 11, 2024
Becker’s Payer Issues recently interviewed 16 healthcare executives about issues that are presenting challenges to the payer community. In today’s evolving healthcare landscape, it’s not just insurance payers feeling the strain of regulatory and political...
by John Warren | Jul 22, 2024
The Centers for Medicare & Medicaid Services (CMS) recently unveiled a proposal in the 2025 Medicare Physician Fee Schedule to cover Digital Mental Health Treatment (DMHT) devices. This policy marks a significant step towards integrating digital health...
by John Warren | Apr 16, 2024
In their FY 2025 Inpatient Prospective Payment System proposed rule, CMS proposes a policy that would increase Medicare payment for gene therapy targeting sickle cell disease. CMS asserts that these additional New Technology Add-on Payments would increase access to...
by John Warren | Apr 15, 2024
As a part of the CMS FY 2025 Inpatient Prospective Payment System proposed rule, CMS followed up on its promise from last year to propose policies that would help the hospital industry to maintain access to essential medicines. But could this Medicare Essential...
by John Warren | Feb 15, 2024
Last April, the Centers for Medicare & Medicaid Services (CMS) released the 2024 Medicare Part D rule. CMS recently issued a list of frequently asked questions addressing parts of these Medicare Advantage coverage criteria and utilization management requirements...
